NuVasive, Inc. provided a financial guidance for the fourth quarter and full year 2016. The company anticipates full year 2016 revenue will be approximately $956 million, reflecting 17.9% year-over-year growth, or 17.6% on a constant currency basis. Full year 2016 pro forma revenue, assuming acquisitions are included in the company’s financial results for the entire fiscal year, is expected to grow 8.7% on a constant currency basis. Additionally, the company expects full year 2016 non-GAAP operating profit margin will be in line with previous guidance of 16.0%. The company anticipates preliminary fourth quarter 2016 revenue performance of approximately $265 million. The company expects full year 2017 revenue will be approximately $1.065 billion, reflecting 11.4% year-over-year growth, or 12.4% on a constant currency basis. Full year 2017 pro forma revenue, assuming acquisitions are included in the company’s financial results for the entire fiscal year, is expected to grow 8.7% on a constant currency basis, in line with the high single-digit long-term organic revenue growth target that the company communicated previously. Revenue guidance for the full year 2017 includes approximately $10 million in year-over-year currency headwinds. Additionally, the company expects full year 2017 non-GAAP operating profit margin expansion of approximately 100 basis points compared to full year 2016.